
Heart disease is the leading cause of death globally. And while genetics play a role, a significant proportion of cardiovascular risk is shaped by lifestyle — what we eat, how we move, how we sleep, and how we manage stress. The good news is that lifestyle-driven risk is modifiable. And among the evidence-based nutritional tools available, omega-3 fatty acids stand out.
How Heart Disease Develops
The Role of Cholesterol
Cholesterol is not inherently harmful — it is essential. It forms cell membranes, serves as a precursor to hormones and enzymes, and participates in energy metabolism. The problem arises when circulating cholesterol concentrations exceed what the blood can safely carry.
Excess cholesterol is deposited on the inner walls of blood vessels — a process called atherosclerosis. This starts early in life and progresses at rates shaped by genetics and lifestyle. As deposits accumulate, blood vessels narrow. When a major vessel narrows critically, or when a deposit ruptures and causes a clot, the result is a heart attack or stroke.
The Role of Endothelial Injury
The innermost layer of blood vessels — the endothelium — is in constant contact with fast-moving blood. Micro-abrasions in this layer, normally repaired efficiently, become sites of cholesterol deposition when repair mechanisms are sluggish or circulating cholesterol is high. Lifestyle factors — poor diet, inactivity, smoking, obesity — slow endothelial repair and accelerate deposition.
Lipoproteins: The Carriers That Matter
Cholesterol travels in the blood attached to lipoproteins. LDL and VLDL transport cholesterol into the body — they are the vehicles that deposit cholesterol into arterial walls. HDL carries cholesterol away from blood vessels back to the liver. More HDL, less LDL and VLDL — this is the balance that protects cardiovascular health.
How Omega-3 Fatty Acids Protect the Heart
- Lower triglycerides — omega-3s reduce VLDL production in the liver and increase clearance of fat-carrying particles, resulting in lower circulating triglycerides, one of the most consistent findings in cardiovascular research
- Reduce arterial inflammation — EPA and DHA generate specialised pro-resolving mediators (resolvins, protectins, maresins) that actively terminate vascular inflammation, reducing the stimulus for plaque formation and instability
- Stabilise existing plaques — by reducing inflammation and oxidative stress, omega-3s shift established plaques toward more stable, less rupture-prone states
- Anti-thrombotic effects — EPA and DHA reduce platelet aggregation and thromboxane activity, lowering the risk of blood clot formation that triggers heart attacks and strokes
- Improve endothelial function — omega-3s enhance nitric oxide availability, causing blood vessels to dilate and reducing the mechanical stress that initiates endothelial injury
- Modest blood pressure reduction — through vascular and renal mechanisms, omega-3s produce small but measurable reductions in systolic and diastolic blood pressure
ALA — The Plant-Based Option
For those who do not consume fatty fish, ALA (alpha-linolenic acid) from flaxseed, walnuts, and chia provides a plant-based pathway to cardiovascular support. While ALA conversion to EPA and DHA in the body is limited, ALA exerts independent cardiovascular benefits — improving endothelial function, reducing inflammation, and modifying lipid profiles. It is a meaningful contribution to heart health and a valuable strategy when fish intake is low or not preferred.
Why Supplementation Often Makes Sense
Achieving the amounts of omega-3 associated with cardiovascular benefit through diet alone is challenging — particularly given uncertainty about food sources and omega-3 content. Supplementation provides a reliable, consistent intake, especially relevant for medium-term risk management alongside lifestyle changes.
References
- AJCN. Dietary cholesterol and cardiovascular disease: systematic review and meta-analysis.
- NHLBI, NIH. Cholesterol and your heart — what you need to know.
- AHA. Dietary cholesterol and cardiovascular risk: science advisory. Circulation.
- Wang T, et al. Omega-3 and dyslipidaemia: continuous dose-response meta-analysis. JAHA. 2023.
- Abdelhamid AS, et al. Omega-3 for primary and secondary prevention of cardiovascular disease. Cochrane. 2020.
Johns Hopkins Medicine. Omega-3 fatty acids and coronary heart disease.

Previous Post